Moreover, there was a significant reduction in LS-mean change in AUC Glucose0-2h from baseline across the high GLP-1 group [LS-mean change from baseline -263.89 mmol/L (95% CI -384.74, -143.04)]
Treatment may include anticoagulant medications, thrombolytic therapy (clot disorders), and surgical intervention in severe cases
Given the high cost of GLP-1s, the patients in that arm of the study may also have had greater access to resources (exercise programs, health coaches, and nutritionists), she says
Fluctuating Side Effects and Restarting Challenges Paradoxically, while some individuals extend doses to manage side effects, this approach can lead to its own set of challenges: Unpredictable Side Effect Patterns: The gastrointestinal side effects (nausea, constipation, diarrhea) that some people seek to mitigate by extending doses can become more unpredictable